PHILADELPHIA (May 31, 2024) — Fox Chase Cancer Center and Temple Health researchers will participate in the presentation and discussion of six research projects and two other speaking engagements at the 2024 American Society of Clinical Oncology Annual Meeting, which is being held May 31-June 4 in Chicago.
Posters and Abstracts
June 2
Title: Utility of Axillary Surgery in Patients with De Novo Metastatic Breast Cancer Undergoing Surgery of the Primary Site.
Date: June 2, 2024; 9:00 AM CDT
Location: Hall A Abstract 1086, Poster Board 64
Presenter: Mahtab Vasigh, MD, Fox Chase Cancer Center
Title: Does Sidedness Predict Risk of Perforation with Chemotherapy in Colon Cancer? Results from the National Inpatient Samples Database (NISD).
Date: June 2, 2024; 4:30 PM CDT
Location: Hall D2 Abstract e15591
Presenter: Jasmeet Kaur, MD, Fox Chase Cancer Center
June 3
Title: A Longitudinal, Palliative Care Educational Pilot in Hematology-Oncology Fellowship Training.
Date: June 3, 2024; 9:45 AM CDT
Location: E450a Abstract 9007
Presenter: Jessica R Bauman, MD, Fox Chase Cancer Center
Title: Characterization of HER2 Alterations in Lung Adenocarcinoma.
Date: June 3, 2024; 1:30 PM CDT
Location: Hall A Abstract 8534, Poster Board 398
Presenter: Nikita Dahake, MD, Temple University Hospital
Title: Tazemetostat in Combination with Topotecan and Pembrolizumab in Patients with Recurrent Small Cell Lung Cancer.
Date: June 3, 2024 1:30 PM CDT
Location: Hall A Abstract TPS8130, Poster Board 384b
Presenter: Parth Anil Desai, MD, MBBS, Fox Chase Cancer Center
June 4
Title: A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment-Naïve Metastatic Pancreatic Cancer (GIANT): ECOG-ACRIN EA2186.
Date: June 4, 2024; 10:45 AM CDT
Location: Hall D1 Abstract 4003
Presenter: Efrat Dotan, MD, Fox Chase Cancer Center
Other Speaking Engagements/Publications
May 31
Title: Optimal Treatment Intensity for Frontline Therapy for Advanced Urothelial Cancer: Which Regimen for Which Patient?
Date: May 31, 2024; 1:00 PM CDT
Location: E450a
Presenter: Pooja Ghatalia, MD, Fox Chase Cancer Center
Title: The Value of Blinded Independent Central Review (BICR) in Recent Trials in Non-Small Cell Lung Cancer (NSCLC).
Publication Only: Journal of Clinical Oncology 42, 2024 (suppl 16; abstract e23000)
Martin J. Edelman, MD, FACP, Fox Chase Cancer Center